S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
Log in

Brainsway Stock Forecast, Price & News

+0.53 (+6.06 %)
(As of 02/24/2021 12:00 AM ET)
Today's Range
Now: $9.28
50-Day Range
MA: $8.64
52-Week Range
Now: $9.28
Volume262,768 shs
Average Volume91,744 shs
Market Capitalization$100.41 million
P/E RatioN/A
Dividend YieldN/A
Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. It offers deep transcranial magnetic stimulation technology for the treatment of major depressive disorders, obsessive-compulsive disorders, bipolar disorders, post traumatic stress disorders, schizophrenia, smoking cessation, Alzheimer's disease, Asperger syndromes, alcohol addictions, attention deficit hyperactivity disorders, Parkinson's disease, and chronic neuropathic pains to transmit electric current flows at varying rates and creating an electromagnetic field that serves to depolarize cortical neurons and activate neural networks in various areas of the brain. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.


BrainsWay readies ADS offering - Seeking Alpha
February 23, 2021 |  seekingalpha.com
Brainsway +4% on Q3 beat, bottom-line up 66%
November 18, 2020 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:BWAY
Phone(722) 581-3140
Year FoundedN/A



Sales & Book Value

Annual Sales$23.10 million
Book Value$2.24 per share


Net Income$-10,330,000.00


Market Cap$100.41 million
Next Earnings Date3/22/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

1.33 out of 5 stars

Medical Sector

665th out of 1,958 stocks

Surgical & Medical Instruments Industry

71st out of 168 stocks

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
+0.53 (+6.06 %)
(As of 02/24/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BWAY News and Ratings via Email

Sign-up to receive the latest news and ratings for BWAY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Brainsway (NASDAQ:BWAY) Frequently Asked Questions

Is Brainsway a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Brainsway in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Brainsway stock.
View analyst ratings for Brainsway
or view top-rated stocks.

What stocks does MarketBeat like better than Brainsway?

Wall Street analysts have given Brainsway a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Brainsway wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Brainsway?

Brainsway saw a increase in short interest in the month of January. As of January 29th, there was short interest totaling 25,700 shares, an increase of 272.5% from the January 14th total of 6,900 shares. Based on an average daily volume of 25,300 shares, the short-interest ratio is presently 1.0 days.
View Brainsway's Short Interest

When is Brainsway's next earnings date?

Brainsway is scheduled to release its next quarterly earnings announcement on Monday, March 22nd 2021.
View our earnings forecast for Brainsway

How were Brainsway's earnings last quarter?

Brainsway Ltd. (NASDAQ:BWAY) released its quarterly earnings results on Wednesday, November, 18th. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.02. The company earned $6.01 million during the quarter, compared to analyst estimates of $5.35 million. Brainsway had a negative trailing twelve-month return on equity of 33.99% and a negative net margin of 34.28%.
View Brainsway's earnings history

How has Brainsway's stock been impacted by Coronavirus?

Brainsway's stock was trading at $8.19 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BWAY stock has increased by 13.3% and is now trading at $9.28.
View which stocks have been most impacted by COVID-19

What guidance has Brainsway issued on next quarter's earnings?

Brainsway updated its fourth quarter 2020 Pre-Market earnings guidance on Tuesday, February, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $6.8-7.1 million, compared to the consensus revenue estimate of $5.68 million.

What price target have analysts set for BWAY?

3 equities research analysts have issued 1-year target prices for Brainsway's shares. Their forecasts range from $12.00 to $13.00. On average, they anticipate Brainsway's stock price to reach $12.67 in the next twelve months. This suggests a possible upside of 36.5% from the stock's current price.
View analysts' price targets for Brainsway
or view top-rated stocks among Wall Street analysts.

Who are Brainsway's key executives?

Brainsway's management team includes the following people:
  • Mr. Hadar Levy, Sr. VP & GM of North America (Age 47, Pay $409k)
  • Ms. Moria Ankri, VP R&D (Age 36, Pay $176k)
  • Dr. David Zacut, Founder & Chairman (Age 68)
  • Dr. Christopher R. von Jako Ph.D., Pres & CEO
  • Mr. Avner Hagai, Founder & Independent Vice-Chairman (Age 65)
  • Prof. Abraham Zangen, Co-Founder, Member of Scientific Advisory Board & Director (Age 51)
  • Dr. Yiftach Roth, Founder & Chief Scientific Officer (Age 50)
  • Mr. Christopher J. Boyer Ph.D., VP of Global Marketing
  • Dr. Aron Tendler, Chief Medical Officer

Who are some of Brainsway's key competitors?

What other stocks do shareholders of Brainsway own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Brainsway investors own include AbbVie (ABBV), Advanced Micro Devices (AMD), Enterprise Products Partners (EPD), Pfizer (PFE), Neuronetics (STIM), Boingo Wireless (WIFI), Ampio Pharmaceuticals (AMPE), Eastman Chemical (EMN), Enbridge (ENB) and Energy Transfer (ET).

When did Brainsway IPO?

(BWAY) raised $30 million in an initial public offering (IPO) on Wednesday, April 17th 2019. The company issued 2,500,000 shares at a price of $11.94 per share. Cantor served as the underwriter for the IPO.

What is Brainsway's stock symbol?

Brainsway trades on the NASDAQ under the ticker symbol "BWAY."

Who are Brainsway's major shareholders?

Brainsway's stock is owned by many different retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (0.20%).

Which institutional investors are buying Brainsway stock?

BWAY stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.

How do I buy shares of Brainsway?

Shares of BWAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Brainsway's stock price today?

One share of BWAY stock can currently be purchased for approximately $9.28.

How much money does Brainsway make?

Brainsway has a market capitalization of $100.41 million and generates $23.10 million in revenue each year. The company earns $-10,330,000.00 in net income (profit) each year or ($0.50) on an earnings per share basis.

How many employees does Brainsway have?

Brainsway employs 107 workers across the globe.

What is Brainsway's official website?

The official website for Brainsway is www.brainsway.com.

Where are Brainsway's headquarters?

Brainsway is headquartered at 19 HARTUM STREET BYNET BUILDING 3RD FL Har HaHotzvim, Jerusalem L3, 9777518.

How can I contact Brainsway?

Brainsway's mailing address is 19 HARTUM STREET BYNET BUILDING 3RD FL Har HaHotzvim, Jerusalem L3, 9777518. The company can be reached via phone at (722) 581-3140 or via email at [email protected]

This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.